Vivesto AB

Suède

 
Quantité totale PI 18
Rang # Quantité totale PI 82 995
Note d'activité PI 2,1/5.0    18
Rang # Activité PI 46 256
Symbole boursier VIVE (stockholm)
ISIN SE0000722365
Capitalisation 145.0M  (SEK)
Classe Nice dominante Produits pharmaceutiques, vétéri...

Brevets

Marques

4 2
1 2
1 2
6
 
Dernier brevet 2024 - Solubilizing compounds
Premier brevet 2002 - Therapeutic compounds
Dernière marque 2023 - PACCAL VET
Première marque 2009 - Paccal Vet

Industrie (Classification de Nice)

Derniers inventions, produits et services

2023 P/S pharmaceutical preparations for veterinary purposes for the treatment of cancer
Invention Solubilizing compounds. The present invention relates to tertiary amide compounds of formula (II)...
P/S Drug delivery agents that facilitate the delivery of pharmaceutical preparations..
P/S Medicines for animals, veterinary preparations, veterinary vaccines, diagnostic preparations for ...
2021 P/S Laboratory chemicals for scientific use; chemicals for use in science Pharmaceutical preparations...
P/S Laboratory chemicals for scientific use namely, active chemical ingredients for use in the manufa...
P/S Laboratory chemicals for scientific use; chemicals for use in science. Pharmaceutical preparatio...
P/S Laboratory chemicals for scientific use; chemicals for use in science. Pharmaceutical preparation...
Invention Drug delivery system for administration of poorly water soluble pharmaceutically active substance...
2018 Invention Method for producing n-retinoylcysteic acid alkyl ester. A method for producing derivatives of N-...
2014 P/S Medicines for human purposes; human cancer medicine. Scientific and technological services and re...
2010 P/S Medicines for veterinary purposes, namely for the prevention and treatment of veterinary cancer.
2009 P/S Pharmaceutical preparations for veterinary purposes.
P/S Medicines for veterinary purposes. Scientific and technological services and research and design ...
2002 Invention Therapeutic compounds. A group of new compounds, N-(all-trans-Retinoyl)-L-cysteic acid, N-(13-cis...